Rezolute (RZLT) Total Non-Current Liabilities (2011 - 2026)

Rezolute's (RZLT) quarterly Total Non-Current Liabilities came in at $8.1 million in Q1 2026, down 30.55% year-on-year from $11.7 million in Q1 2025, and down 20.01% quarter-over-quarter from $10.1 million in Q4 2025.

Rezolute (RZLT) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Rezolute has disclosed Total Non-Current Liabilities across 14 years of filings, most recently posting $8.1 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $8.1 million, down 30.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (down 30.55% YoY), and the FY2025 annual result was $12.9 million, up 14.46% from the prior year.
  • Total Non-Current Liabilities came in at $8.1 million for Q1 2026 at Rezolute, down from $10.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $17.3 million in Q1 2022 to a low of $2.5 million in Q3 2022.
  • The 5-year median for Total Non-Current Liabilities is $10.0 million (2023), against an average of $9.8 million.
  • Across the five-year window, Total Non-Current Liabilities slumped 85.28% in 2022 and soared 263.56% in 2023, its largest moves.
  • Rezolute's Total Non-Current Liabilities stood at $8.5 million in 2022, then climbed by 17.06% to $10.0 million in 2023, then advanced by 19.88% to $11.9 million in 2024, then fell by 15.02% to $10.1 million in 2025, then dropped by 20.01% to $8.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $8.1 million (Q1 2026), $10.1 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Rezolute 520.13 Mn 520.13 Mn - 8.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.12 Mn
Dec 31, 2025 10.15 Mn
Sep 30, 2025 11.01 Mn
Jun 30, 2025 12.90 Mn
Mar 31, 2025 11.69 Mn
Dec 31, 2024 11.94 Mn
Sep 30, 2024 9.52 Mn
Jun 30, 2024 11.27 Mn
Mar 31, 2024 16.42 Mn
Dec 31, 2023 9.96 Mn
Sep 30, 2023 9.01 Mn
Jun 30, 2023 7.14 Mn
Mar 31, 2023 6.44 Mn
Dec 31, 2022 8.51 Mn
Sep 30, 2022 2.48 Mn
Jun 30, 2022 2.54 Mn
Mar 31, 2022 17.27 Mn
Dec 31, 2021 20.76 Mn
Sep 30, 2021 16.83 Mn
Jun 30, 2021 16.12 Mn